DOCSLIB.ORG

Cemip (NM 030728) Mouse Tagged ORF Clone – MR217955

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Cemip (NM 030728) Mouse Tagged ORF Clone – MR217955 OriGene Technologies, Inc. 9620 Medical Center Drive, Ste 200 Rockville, MD 20850, US Phone: +1-888-267-4436 [email protected] EU: [email protected] CN: [email protected] Product datasheet for MR217955 Cemip (NM_030728) Mouse Tagged ORF Clone Product data: Product Type: Expression Plasmids Product Name: Cemip (NM_030728) Mouse Tagged ORF Clone Tag: Myc-DDK Symbol: Cemip Synonyms: 12H19.01.T7; 6330404C01Rik; 9930013L23Rik; AY007814; Kiaa1199 Vector: pCMV6-Entry (PS100001) E. coli Selection: Kanamycin (25 ug/mL) Cell Selection: Neomycin ORF Nucleotide >MR217955 ORF sequence Sequence: Red=Cloning site Blue=ORF Green=Tags(s) TTTTGTAATACGACTCACTATAGGGCGGCCGGGAATTCGTCGACTGGATCCGGTACCGAGGAGATCTGCC GCCGCGATCGCC ATGAGAGCTTCTGGGAGGCACGATGTCTCCCTCAAGATTGTGCTGGCCACGGGCTGCCTCCTCCTGGCCA ACTTCTCAGGGGCCTCATCTGCAGTGGCAACTGAGTGTCCTGATCAGAGTCCTGAGCTGCAGCCTTGGAG CCCTGGCCATAACAGAGACTATCAAGTACACATTGGCCATGGCAGGAAACTACTGCTCACCTCTTCTGCC ACAGTCCACTCCATCACTATCTCAGGGGGAGGAAAGCTTGTCATTAAAGACCACCATGAGCACATTGTGC TGCGTACCCGGTACATCCTGATTGATGACGGTGGAGAGCTGCATGCTGGGAGTGCCCTTTGCCCTTTTGA GGGCAATTTCAGTATTGTGCTGTATGGAAGGGCTGATGAAAACATCCTGCCAGACCCTTACTATGGCCTG AAGTACATCGGAGTAGACAAAGGAGGCACTCTTGAATTACATGGGCAGAAAAAGCTTTCCTGGACTTTTC TAAACAAGACCCTTCATCCTGGTGGCATGCAGGAGGGAGGATATTTTTTTGAAAGGAGCTGGGGCCACCG TGGAGTCATTGTCCATGTCATTGATGCCAAATTGGGCACAGTTGTCCATTCTGACCGGTTTGACACTTAC AGATCCAAAAAAGAGAGTGAACGTCTGGTCCAGTATTTGAATGCAGTGCCCGATGGCAGGATTCTTTCTG TCGCAGTGAATGATGAAGGTTCTAGAAACCTGGATGACACAGCCCGGAAGGCAATGACCAAACTGGGCAG CAAGCACTTCCTCCACCTTGGATTTAGACACCCTTGGAGCTTCATCACTGTGAAAGGAAATCCCTCCTCT TCAGTTGAAGACCACATTGAATACCATGGTCACAAAGGCTCGGCTGCTGCCCGGGTTTTCAAACTGTTCC AGACAGAGCATGGTGAACATTTCAATGTTTCTTCATCCAGCGAATGGGTTCAAGATGTGGAATGGACAGA GTGGTTTGACCATGATAAGGTGCCTCAGAGCAAAGGTGGGGAGAAAATTTCAGATCTGCGAGCAGCTTAC CCAGGAAAAATCTGCAATCGACCCATTGATATACAGGCCACAACAATGGATGGAGTCGCCCTCAGCACTG AGGTTGTCTACAAAAATGGCCAAGATTACAGGTTTGCTTGCTACACCCGGGGCAGAGCCTGCCGAAGCTA TCGAGTGCGATTCTTATGTGGAAAACCCGTGAGGCCCAAGCTCACGGTTAGCATCGACACCAACGTAAAC AGCACCATCCTGAGTCTGGTGGACAATGTGCGGTCATGGAGGCCTGGAGACACCCTGGTTGTTGCCAGCA CTGACTATTCGATGTACCAGGCAGAAGAGTTCCGGGTGCTCCCCTGCAAAGCTTGCACCTCTACACAGGT CAAGGTGGCAGGGAAACCACAGTACCTACATATTGGGGAGGAGATTGATGGTGTAGACATGCGGGCTGAG GTCGGACTCCTGACTCGGAACATTGTGGTGATGGGGGAGATGGAGGACAGATGCTACCCCTACACCAATC This product is to be used for laboratory only. Not for diagnostic or therapeutic use. View online » ©2021 OriGene Technologies, Inc., 9620 Medical Center Drive, Ste 200, Rockville, MD 20850, US 1 / 4 Cemip (NM_030728) Mouse Tagged ORF Clone – MR217955 ACATCTGTGACTTCTTTGACTTCGATACCTTTGGGGGCCACATCAAGTTTGCACTGGGGTTTAAAGCAGC CCACTTGGAGGGCGTGGAGCTGAAGTACATGGGGCAGCAGCTGGTGGGCCAGTACCCAATTCACTTCCAC CTGGCTGGAGATTTGGATGAACAGGGAGGCTATGACCCCCCTACCTACATCAGGGACCTCTCCATTCATC ACACATTCTCCCGCTGCGTCACTGTCCATGGCTCCAACGGTCTGTTGATCAAGGATGTTGTGGGCTATAA TTCTTTGGGCCACTGCTTCTTCACTGAAGATGGGCCAGAGGAACGCAACACTTTTGACCACTGCCTTGGC CTCCTTGTTAAGTCAGGGACCCTTCTCCCATCCGATCGGGATAGCAGGATGTGCAAAGTGATCACAGAGG ACTCATACCCAGGGTACATCCCCAAGCCCAGGCAGGACTGCAATGCCGTGTCCACATTCTGGATGGCGAA TCCCAACAACAATCTCATCAACTGCGCAGCTGCAGGGTCCGAGGAAACTGGATTTTGGTTCATTTTTCAC CATGTGCCAACGGGCCCCTCTGTGGGAATGTACTCTCCAGGTTATTCTGAGCACATTCCACTGGGTAAAT TCTACAACAATCGAGCACATTCTAACTACCGGGCTGGCATGATCATAGACAATGGAGTCAAGACAACTGA GGCCTCAGCCAAGGATAAACGGCCCTTCCTCTCCATCATCTCTGCCAGGTACAGCCCTCACCAGGACGCA GACCCACTGAAACCTCGGGAACCAGCCATTATCCGACACTTTACTGCCTACAAGAACCAGGATCATGGAG CCTGGCTGCGGGGTGGGGATGTGTGGCTGGACAGCTGTAGGTTTGCTGATAATGGCATTGGTCTGACCCT GGCCAGTGGTGGAACCTTCCCATATGATGATGGCTCCAAGCAGGAGATAAAGAACAGCTTGTTTGTTGGC GAGAGTGGCAATGTGGGCACAGAAATGATGGACAACAGGATCTGGGGTCCAGGTGGCTTGGACCACAGTG GAAGGACCCTCCCTATTGGCCAGAATTTTCCCATTAGAGGAATTCAGTTCTACGATGGCCCCATCAACAT CCAGAACTGCACCTTCCGCAAGTTCGCGGCCCTCGAGGGCAGGCACACCAGTGCCTTGGCCTTCCGCCTA AACAATGCCTGGCAAAGCTGCCCTCACAACAATGTGACCAACATAGCCTTTGAGGATGTCCCGATTACTT CCAGAGTGTTCTTCGGAGAGCCCGGGCCCTGGTTCAACCAGCTGGACATGGACGGGGACAAGACATCTGT GTTCCATGATCTGGACGGCTCTGTGTCGGAGTACCCTGGCTCCTATCTCACTAAGGACGACAACTGGCTG GTCCGACACCCAGACTGCATCAATGTCCCAGACTGGAGAGGGGCCATCTGCAGTGGGCGCTATGCACAGA TGTACATCCAGGCCTACAAGAGCAGCAATCTGCGCATGAAGATCATTAAGAATGACTTCCCCAGCCACCC GCTCTACCTGGAGGGGGCCCTCACCAGGAGCACCCACTACCAGCAGTATCAGCCTGTCATCACCCTGCAG AAGGGCTATACTATCCACTGGGACCAGACAGCCCCCGCCGAGCTTGCCATCTGGCTCATCAACTTCAACA AGGGTGACTGGATCCGAGTGGGGCTCTGCTACCCAAGAGGCACCACCTTTTCCATCCTTTCAGATGTTCA CAATCGCCTGCTAAAGCAAACGTCCAAGACTGGGACCTTTGTGAGGACTCTGCAGATGGACAAAGTTGAG CAGAGCTATCCTGGCAGGAGCCACTACTACTGGGATGAGGATTCTGGGTTGCTCTTCTTGAAATTAAAAG CCCAGAACGAAAGGGAGAAATTTGCTTTCTGCTCCATGAAGGGCTGTGAGAGAATCAAGATTAAAGCTCT GCTCCCAAGAAATGCAGGCATCAGCGACTGCACAGCCACGGCTTACCCCAGGTTCACTGAGAGGGCCATA GTGGATGTACCAATGCCCAGGAAGCTCTTTGGGGCTCAGCTGAAGACAAAAGACCACTTCCTGGAAGTGA AGATGGAAAGTTCCAGGCAGCACTTCTTCCACCTTCGGAATGACTTCGCTTATATTGAAGTGGATGGGAG GAGGTACCCTTGCTCAGAAGATGGCATCCAGATAGTGGTGATTGATGGGAGTCGAGGTCACGTGGTGAGC CACGGCAGCTTCAGAAATGCCATTCTGCAGGGCATACCCTGGCAGCTCTTCAACTACGTGGCAGCTATCC CTGACAATTCCATAGTGCTCATGGCATCAAAGGGCAGATACATCACCAGAGGCCCATGGACCAGGGTGCT GGAAAAGCTTGGGGCAGACAAAGGTCTCAAGTTGAAAGAAAAGATGGCGTTCGTCGGCTTCAAAGGCAGC TTCCGACCCATCTGGGTGACTCTGGAGACTGAGGACCACAAAGCCAAAATCTTCCAAGTGGTGCCCATCC CTGTGGTGAGAAAGAAGAAGCTG ACGCGTACGCGGCCGCTCGAGCAGAAACTCATCTCAGAAGAGGATCTGGCAGCAAATGATATCCTGGATT ACAAGGATGACGACGATAAGGTTTAA This product is to be used for laboratory only. Not for diagnostic or therapeutic use. ©2021 OriGene Technologies, Inc., 9620 Medical Center Drive, Ste 200, Rockville, MD 20850, US 2 / 4 Cemip (NM_030728) Mouse Tagged ORF Clone – MR217955 Protein Sequence: >MR217955 protein sequence Red=Cloning site Green=Tags(s) MRASGRHDVSLKIVLATGCLLLANFSGASSAVATECPDQSPELQPWSPGHNRDYQVHIGHGRKLLLTSSA TVHSITISGGGKLVIKDHHEHIVLRTRYILIDDGGELHAGSALCPFEGNFSIVLYGRADENILPDPYYGL KYIGVDKGGTLELHGQKKLSWTFLNKTLHPGGMQEGGYFFERSWGHRGVIVHVIDAKLGTVVHSDRFDTY RSKKESERLVQYLNAVPDGRILSVAVNDEGSRNLDDTARKAMTKLGSKHFLHLGFRHPWSFITVKGNPSS SVEDHIEYHGHKGSAAARVFKLFQTEHGEHFNVSSSSEWVQDVEWTEWFDHDKVPQSKGGEKISDLRAAY PGKICNRPIDIQATTMDGVALSTEVVYKNGQDYRFACYTRGRACRSYRVRFLCGKPVRPKLTVSIDTNVN STILSLVDNVRSWRPGDTLVVASTDYSMYQAEEFRVLPCKACTSTQVKVAGKPQYLHIGEEIDGVDMRAE VGLLTRNIVVMGEMEDRCYPYTNHICDFFDFDTFGGHIKFALGFKAAHLEGVELKYMGQQLVGQYPIHFH LAGDLDEQGGYDPPTYIRDLSIHHTFSRCVTVHGSNGLLIKDVVGYNSLGHCFFTEDGPEERNTFDHCLG LLVKSGTLLPSDRDSRMCKVITEDSYPGYIPKPRQDCNAVSTFWMANPNNNLINCAAAGSEETGFWFIFH HVPTGPSVGMYSPGYSEHIPLGKFYNNRAHSNYRAGMIIDNGVKTTEASAKDKRPFLSIISARYSPHQDA DPLKPREPAIIRHFTAYKNQDHGAWLRGGDVWLDSCRFADNGIGLTLASGGTFPYDDGSKQEIKNSLFVG ESGNVGTEMMDNRIWGPGGLDHSGRTLPIGQNFPIRGIQFYDGPINIQNCTFRKFAALEGRHTSALAFRL NNAWQSCPHNNVTNIAFEDVPITSRVFFGEPGPWFNQLDMDGDKTSVFHDLDGSVSEYPGSYLTKDDNWL VRHPDCINVPDWRGAICSGRYAQMYIQAYKSSNLRMKIIKNDFPSHPLYLEGALTRSTHYQQYQPVITLQ KGYTIHWDQTAPAELAIWLINFNKGDWIRVGLCYPRGTTFSILSDVHNRLLKQTSKTGTFVRTLQMDKVE QSYPGRSHYYWDEDSGLLFLKLKAQNEREKFAFCSMKGCERIKIKALLPRNAGISDCTATAYPRFTERAI VDVPMPRKLFGAQLKTKDHFLEVKMESSRQHFFHLRNDFAYIEVDGRRYPCSEDGIQIVVIDGSRGHVVS HGSFRNAILQGIPWQLFNYVAAIPDNSIVLMASKGRYITRGPWTRVLEKLGADKGLKLKEKMAFVGFKGS FRPIWVTLETEDHKAKIFQVVPIPVVRKKKL TRTRPLEQKLISEEDLAANDILDYKDDDDKV Restriction Sites: SgfI-MluI Cloning Scheme: This product is to be used for laboratory only. Not for diagnostic or therapeutic use. ©2021 OriGene Technologies, Inc., 9620 Medical Center Drive, Ste 200, Rockville, MD 20850, US 3 / 4 Cemip (NM_030728) Mouse Tagged ORF Clone – MR217955 Plasmid Map: ACCN: NM_030728 ORF Size: 4086 bp OTI Disclaimer: The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info OTI Annotation: This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene. RefSeq: NM_030728.3 RefSeq Size: 7114 bp RefSeq ORF: 4086 bp Locus ID: 80982 UniProt ID: Q5M9P4, Q8BI06 MW: 153 kDa Gene Summary: Mediates depolymerization of hyaluronic acid (HA) via the cell membrane-associated clathrin- coated pit endocytic pathway. Binds to hyaluronic acid. Hydrolyzes high molecular weight hyaluronic acid to produce an intermediate-sized product, a process that may occur through rapid vesicle endocytosis and recycling without intracytoplasmic accumulation or digestion in lysosomes. Involved in hyaluronan catabolism in the dermis of the skin and arthritic synovium. Positively regulates epithelial-mesenchymal transition (EMT), and hence tumor cell growth, invasion and cancer dissemination. In collaboration with HSPA5/BIP, promotes cancer cell migration in a calcium and PKC-dependent manner. May be involved in hearing. [UniProtKB/Swiss-Prot Function] This product is to be used for laboratory only. Not for diagnostic or therapeutic use. ©2021 OriGene Technologies, Inc., 9620 Medical Center Drive, Ste 200, Rockville, MD 20850, US 4 / 4.
Load more

Recommended publications
  • CEMIP Sirna (H): Sc-90061
    SANTA CRUZ BIOTECHNOLOGY, INC. CEMIP siRNA (h): sc-90061 BACKGROUND STORAGE AND RESUSPENSION Encoding more than 700 genes, chromosome 15 is made up of approximately Store lyophilized siRNA duplex at -20° C with desiccant. Stable for at least 106 million base pairs and is about 3% of the human genome. Angelman and one year from the date of shipment. Once resuspended, store at -20° C, Prader-Willi syndromes are associated with loss of function or deletion of avoid contact with RNAses and repeated freeze thaw cycles. genes in the 15q11-q13 region. In the case of Angelman syndrome, this loss Resuspend lyophilized siRNA duplex in 330 µl of the RNAse-free water is due to inactivity of the maternal 15q11-q13-encoded UBE3A gene in the provided. Resuspension of the siRNA duplex in 330 µl of RNAse-free water brain by either chromosomal deletion or mutation. In cases of Prader-Willi makes a 10 µM solution in a 10 µM Tris-HCl, pH 8.0, 20 mM NaCl, 1 mM syndrome, there is a partial or complete deletion of this region from the pater- EDTA buffered solution. nal copy of chromosome 15. Tay-Sachs disease is a lethal disorder associated with mutations of the HEXA gene, which is encoded by chromosome 15. APPLICATIONS Marfan syndrome is associated with chromosome 15 through the FBN1 gene. CEMIP siRNA (h) is recommended for the inhibition of CEMIP expression in REFERENCES human cells. 1. Hurowitz, G.I., et al. 1993. Neuropsychiatric aspects of adult-onset SUPPORT REAGENTS Tay-Sachs disease: two case reports with several new findings.
    [Show full text]
  • Supplementary Table S4. FGA Co-Expressed Gene List in LUAD
    Supplementary Table S4. FGA co-expressed gene list in LUAD tumors Symbol R Locus Description FGG 0.919 4q28 fibrinogen gamma chain FGL1 0.635 8p22 fibrinogen-like 1 SLC7A2 0.536 8p22 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 DUSP4 0.521 8p12-p11 dual specificity phosphatase 4 HAL 0.51 12q22-q24.1histidine ammonia-lyase PDE4D 0.499 5q12 phosphodiesterase 4D, cAMP-specific FURIN 0.497 15q26.1 furin (paired basic amino acid cleaving enzyme) CPS1 0.49 2q35 carbamoyl-phosphate synthase 1, mitochondrial TESC 0.478 12q24.22 tescalcin INHA 0.465 2q35 inhibin, alpha S100P 0.461 4p16 S100 calcium binding protein P VPS37A 0.447 8p22 vacuolar protein sorting 37 homolog A (S. cerevisiae) SLC16A14 0.447 2q36.3 solute carrier family 16, member 14 PPARGC1A 0.443 4p15.1 peroxisome proliferator-activated receptor gamma, coactivator 1 alpha SIK1 0.435 21q22.3 salt-inducible kinase 1 IRS2 0.434 13q34 insulin receptor substrate 2 RND1 0.433 12q12 Rho family GTPase 1 HGD 0.433 3q13.33 homogentisate 1,2-dioxygenase PTP4A1 0.432 6q12 protein tyrosine phosphatase type IVA, member 1 C8orf4 0.428 8p11.2 chromosome 8 open reading frame 4 DDC 0.427 7p12.2 dopa decarboxylase (aromatic L-amino acid decarboxylase) TACC2 0.427 10q26 transforming, acidic coiled-coil containing protein 2 MUC13 0.422 3q21.2 mucin 13, cell surface associated C5 0.412 9q33-q34 complement component 5 NR4A2 0.412 2q22-q23 nuclear receptor subfamily 4, group A, member 2 EYS 0.411 6q12 eyes shut homolog (Drosophila) GPX2 0.406 14q24.1 glutathione peroxidase
    [Show full text]
  • Supplementary Material
    BMJ Publishing Group Limited (BMJ) disclaims all liability and responsibility arising from any reliance Supplemental material placed on this supplemental material which has been supplied by the author(s) J Neurol Neurosurg Psychiatry Page 1 / 45 SUPPLEMENTARY MATERIAL Appendix A1: Neuropsychological protocol. Appendix A2: Description of the four cases at the transitional stage. Table A1: Clinical status and center proportion in each batch. Table A2: Complete output from EdgeR. Table A3: List of the putative target genes. Table A4: Complete output from DIANA-miRPath v.3. Table A5: Comparison of studies investigating miRNAs from brain samples. Figure A1: Stratified nested cross-validation. Figure A2: Expression heatmap of miRNA signature. Figure A3: Bootstrapped ROC AUC scores. Figure A4: ROC AUC scores with 100 different fold splits. Figure A5: Presymptomatic subjects probability scores. Figure A6: Heatmap of the level of enrichment in KEGG pathways. Kmetzsch V, et al. J Neurol Neurosurg Psychiatry 2021; 92:485–493. doi: 10.1136/jnnp-2020-324647 BMJ Publishing Group Limited (BMJ) disclaims all liability and responsibility arising from any reliance Supplemental material placed on this supplemental material which has been supplied by the author(s) J Neurol Neurosurg Psychiatry Appendix A1. Neuropsychological protocol The PREV-DEMALS cognitive evaluation included standardized neuropsychological tests to investigate all cognitive domains, and in particular frontal lobe functions. The scores were provided previously (Bertrand et al., 2018). Briefly, global cognitive efficiency was evaluated by means of Mini-Mental State Examination (MMSE) and Mattis Dementia Rating Scale (MDRS). Frontal executive functions were assessed with Frontal Assessment Battery (FAB), forward and backward digit spans, Trail Making Test part A and B (TMT-A and TMT-B), Wisconsin Card Sorting Test (WCST), and Symbol-Digit Modalities test.
    [Show full text]
  • Arnau Soler2019.Pdf
    This thesis has been submitted in fulfilment of the requirements for a postgraduate degree (e.g. PhD, MPhil, DClinPsychol) at the University of Edinburgh. Please note the following terms and conditions of use: This work is protected by copyright and other intellectual property rights, which are retained by the thesis author, unless otherwise stated. A copy can be downloaded for personal non-commercial research or study, without prior permission or charge. This thesis cannot be reproduced or quoted extensively from without first obtaining permission in writing from the author. The content must not be changed in any way or sold commercially in any format or medium without the formal permission of the author. When referring to this work, full bibliographic details including the author, title, awarding institution and date of the thesis must be given. Genetic responses to environmental stress underlying major depressive disorder Aleix Arnau Soler Doctor of Philosophy The University of Edinburgh 2019 Declaration I hereby declare that this thesis has been composed by myself and that the work presented within has not been submitted for any other degree or professional qualification. I confirm that the work submitted is my own, except where work which has formed part of jointly-authored publications has been included. My contribution and those of the other authors to this work are indicated below. I confirm that appropriate credit has been given within this thesis where reference has been made to the work of others. I composed this thesis under guidance of Dr. Pippa Thomson. Chapter 2 has been published in PLOS ONE and is attached in the Appendix A, chapter 4 and chapter 5 are published in Translational Psychiatry and are attached in the Appendix C and D, and I expect to submit chapter 6 as a manuscript for publication.
    [Show full text]
  • The Expression of Genes Contributing to Pancreatic Adenocarcinoma Progression Is Influenced by the Respective Environment – Sagini Et Al
    The expression of genes contributing to pancreatic adenocarcinoma progression is influenced by the respective environment – Sagini et al Supplementary Figure 1: Target genes regulated by TGM2. Figure represents 24 genes regulated by TGM2, which were obtained from Ingenuity Pathway Analysis. As indicated, 9 genes (marked red) are down-regulated by TGM2. On the contrary, 15 genes (marked red) are up-regulated by TGM2. Supplementary Table 1: Functional annotations of genes from Suit2-007 cells growing in pancreatic environment Categoriesa Diseases or p-Valuec Predicted Activation Number of genesf Functions activationd Z-scoree Annotationb Cell movement Cell movement 1,56E-11 increased 2,199 LAMB3, CEACAM6, CCL20, AGR2, MUC1, CXCL1, LAMA3, LCN2, COL17A1, CXCL8, AIF1, MMP7, CEMIP, JUP, SOD2, S100A4, PDGFA, NDRG1, SGK1, IGFBP3, DDR1, IL1A, CDKN1A, NREP, SEMA3E SERPINA3, SDC4, ALPP, CX3CL1, NFKBIA, ANXA3, CDH1, CDCP1, CRYAB, TUBB2B, FOXQ1, SLPI, F3, GRINA, ITGA2, ARPIN/C15orf38- AP3S2, SPTLC1, IL10, TSC22D3, LAMC2, TCAF1, CDH3, MX1, LEP, ZC3H12A, PMP22, IL32, FAM83H, EFNA1, PATJ, CEBPB, SERPINA5, PTK6, EPHB6, JUND, TNFSF14, ERBB3, TNFRSF25, FCAR, CXCL16, HLA-A, CEACAM1, FAT1, AHR, CSF2RA, CLDN7, MAPK13, FERMT1, TCAF2, MST1R, CD99, PTP4A2, PHLDA1, DEFB1, RHOB, TNFSF15, CD44, CSF2, SERPINB5, TGM2, SRC, ITGA6, TNC, HNRNPA2B1, RHOD, SKI, KISS1, TACSTD2, GNAI2, CXCL2, NFKB2, TAGLN2, TNF, CD74, PTPRK, STAT3, ARHGAP21, VEGFA, MYH9, SAA1, F11R, PDCD4, IQGAP1, DCN, MAPK8IP3, STC1, ADAM15, LTBP2, HOOK1, CST3, EPHA1, TIMP2, LPAR2, CORO1A, CLDN3, MYO1C,
    [Show full text]
  • UNIVERSITY of CALIFORNIA, SAN DIEGO the Role of Nonsense
    UNIVERSITY OF CALIFORNIA, SAN DIEGO The Role of Nonsense-mediated RNA Decay in Arsenic Toxicity A dissertation submitted in partial satisfaction of the requirements for the degree Doctor of Philosophy in Neurosciences by Alexandra E. Goetz Committee in Charge: Professor Miles Wilkinson, Chair Professor Nicola Allen Professor Jonathan Lin Professor Jens Lykke-Andersen Professor Pamela Mellon 2018 Signature Page The Dissertation of Alexandra E. Goetz is approved, and it is acceptable in quality and form for publication on microfilm and electronically: Chair University of California, San Diego 2018 iii DEDICATION Dedication This work would not have been possible without the support of my family members- my mother, my father, and my brother Matt. Their support to follow my passions, even when the going got tough, helped me finish graduate school, lab change and all. I also want to dedicate this to my husband, Nadav, who was the best shoulder to cry on, cheerleader, and partner to celebrate with through graduate school. iv TABLE OF CONTENTS Table of Contents Signature Page .......................................................................................................................... iii Dedication .................................................................................................................................. iv Table of Contents ........................................................................................................................ v List of Abbreviations ................................................................................................................
    [Show full text]
  • Investigation of the Underlying Genes and Mechanism of Macrophage-Enriched Ruptured Atherosclerotic Plaques Using Bioinformatics Method
    The official journal of the Japan Atherosclerosis Society and the Asian Pacific Society of Atherosclerosis and Vascular Diseases Original Article J Atheroscler Thromb, 2019; 26: 000-000. http://doi.org/10.5551/jat.45963 Investigation of the Underlying Genes and Mechanism of Macrophage-Enriched Ruptured Atherosclerotic Plaques Using Bioinformatics Method Hao Wang, Dongyuan Liu and Hongbing Zhang Department of Neurosurgery, Beijing Luhe Hospital, Capital Medical University, Beijing, China Aim: The study aimed to identify the underlying differentially expressed genes (DEGs) and mechanism of mac- rophage-enriched rupture atherosclerotic plaque using bioinformatics methods. Methods: GSE41571, which includes six stable samples and five ruptured atherosclerotic samples, was down- loaded from the GEO database. After preprocessing, DEGs between ruptured and stable atherosclerotic samples were identified using LIMMA. Gene Ontology biological process (GO_BP) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses of DEGs were performed using the Database for Annotation, Visual- ization, and Integration Discovery (DAVID) online tool. Based on the STRING database, protein-protein inter- actions (PPIs) network among DEGs were constructed. Regulatory relationships between miRNAs/transcrip- tional factors (TFs) and target genes were predicted using Enrichr, and regulatory networks were visualized using Cytoscape. Results: A total of 268 DEGs (64 up-regulated and 204 down-regulated DEGs) were identified between rup- tured and stable samples. In the PPI network, collagen type Ⅲ alpha 1 chain (COL3A1), collagen type I alpha 2 chain (COL1A2), and asporin (ASPN) were more than 15 interaction degrees. In the miRNA-target network, miR21 was highlighted with highest degrees and ASPN could be targeted by miR21. Functional enrichment analysis showed that COL3A1 and COL1A2 were significantly enriched in extracellular matrix organization and cell adhesion GO_BP terms.
    [Show full text]
  • A TBR1-K228E Mutation Induces Tbr1 Upregulation, Altered Cortical
    ORIGINAL RESEARCH published: 09 October 2019 doi: 10.3389/fnmol.2019.00241 A TBR1-K228E Mutation Induces Tbr1 Upregulation, Altered Cortical Distribution of Interneurons, Increased Inhibitory Synaptic Transmission, and Autistic-Like Behavioral Deficits in Mice Chaehyun Yook 1, Kyungdeok Kim 1, Doyoun Kim 2, Hyojin Kang 3, Sun-Gyun Kim 2, Eunjoon Kim 1,2* and Soo Young Kim 4* 1Department of Biological Sciences, Korea Advanced Institute for Science and Technology (KAIST), Daejeon, South Korea, 2Center for Synaptic Brain Dysfunctions, Institute for Basic Science (IBS), Daejeon, South Korea, 3Division of National 4 Edited by: Supercomputing, Korea Institute of Science and Technology Information (KISTI), Daejeon, South Korea, College of Se-Young Choi, Pharmacy, Yeongnam University, Gyeongsan, South Korea Seoul National University, South Korea Mutations in Tbr1, a high-confidence ASD (autism spectrum disorder)-risk gene Reviewed by: encoding the transcriptional regulator TBR1, have been shown to induce diverse Carlo Sala, Institute of Neuroscience (CNR), Italy ASD-related molecular, synaptic, neuronal, and behavioral dysfunctions in mice. Lin Mei, However, whether Tbr1 mutations derived from autistic individuals cause similar Department of Neuroscience, School of Medicine, Case Western Reserve dysfunctions in mice remains unclear. Here we generated and characterized mice University, United States carrying the TBR1-K228E de novo mutation identified in human ASD and identified *Correspondence: various ASD-related phenotypes. In heterozygous mice carrying this mutation Eunjoon Kim =K228E (Tbr1C mice), levels of the TBR1-K228E protein, which is unable to bind target [email protected] =K228E Soo Young Kim DNA, were strongly increased. RNA-Seq analysis of the Tbr1C embryonic brain [email protected] indicated significant changes in the expression of genes associated with neurons, =K228E astrocytes, ribosomes, neuronal synapses, and ASD risk.
    [Show full text]
  • Cell Atlas of Aqueous Humor Outflow Pathways in Eyes of Humans and Four Model Species Provides Insight Into Glaucoma Pathogenesis
    Cell atlas of aqueous humor outflow pathways in eyes of humans and four model species provides insight into glaucoma pathogenesis Tavé van Zyla,b,c,1,2, Wenjun Yanb,c,1, Alexi McAdamsa,b,c, Yi-Rong Pengb,c,3, Karthik Shekhard,e,4, Aviv Regevd,e,f, Dejan Juricg, and Joshua R. Sanesb,c,2 aDepartment of Ophthalmology, Harvard Medical School and Massachusetts Eye and Ear, Boston, MA 02114; bCenter for Brain Science, Harvard University, Cambridge, MA 02138; cDepartment of Molecular and Cellular Biology, Harvard University, Cambridge, MA 02138; dHoward Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, MA 02142; eKoch Institute of Integrative Cancer Research, Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02142; fKlarman Cell Observatory, Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142; and gDepartment of Medicine, Harvard Medical School and Massachusetts General Hospital Cancer Center, Boston, MA 02114 Contributed by Joshua R. Sanes, March 10, 2020 (sent for review January 22, 2020; reviewed by Iok-Hou Pang and Joel S. Schuman) Increased intraocular pressure (IOP) represents a major risk factor juxtacanalicular tissue (JCT) prior to being conveyed into a for glaucoma, a prevalent eye disease characterized by death of specialized vessel called Schlemm canal (SC). From SC, AH exits retinal ganglion cells; lowering IOP is the only proven treatment the eye through a network of collector channels (CCs) continu- strategy to delay disease progression. The main determinant of ous with the venous system. The remaining AH exits the anterior IOP is the equilibrium between production and drainage of chamber via the uveoscleral pathway, draining through the in- aqueous humor, with compromised drainage generally viewed terstices of the ciliary muscle (CM) and ultimately exiting the eye as the primary contributor to dangerous IOP elevations.
    [Show full text]
  • Lncrna LINC00958 Promotes Tumor Progression Through Mir-4306/CEMIP Axis in Osteosarcoma
    European Review for Medical and Pharmacological Sciences 2021; 25: 3182-3199 LncRNA LINC00958 promotes tumor progression through miR-4306/CEMIP axis in osteosarcoma Y. ZHOU1, T. MU2 1Department of Orthopedics, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China 2Department of Stomatology, Emergency General Hospital, Beijing, China Abstract. – OBJECTIVE: To investigate the er gene assay verified that LINC00958 competi- mechanism by which LINC00958 affects osteo- tively bound miR-4306 and repressed its expres- sarcoma progression through miR-4306/CEMIP sion. Silencing of LINC00958 inhibited prolifera- axis. tion, cell cycle, metastasis, and invasion of os- PATIENTS AND METHODS: The microarray teosarcoma cells while inducing cellular apopto- data (GSE66673) for gene expression in osteo- sis. The introduction of miR-4306 inhibitors re- sarcoma cells were obtained from the Gene Ex- versed the tumor-suppressing effect of silenc- pression Omnibus (GEO) database, and differ- ing LINC00958. miR-4306 binds to CEMIP and entially expressed genes were analyzed by bio- suppressed its expression. Xenograft tumor ex- informatics tools. Real-time quantitative PCR periments and tumor metastasis assays in nude (RT-qPCR) was performed to detect the expres- mice demonstrated that silencing LINC00958 in- sion levels of LINC00958, miR-4306, and CEMIP hibited osteosarcoma cells’ growth and metas- in osteosarcoma tissues and cell lines. West- tasis while inhibiting miR-4306 reversed this ef- ern blot was performed to detect the expression fect. Kaplan-Meier analysis showed that high ex- levels of CEMIP. Subcellular fractionation analy- pression of LINC00958 was significantly associ- sis and RNA Fluorescence in situ hybridization ated with poor prognosis of osteosarcoma pa- (FISH) assay were performed to analyze the sub- tients.
    [Show full text]
  • Initiating Cells Using Microfluidic- Based Migration Identifies
    www.nature.com/scientificreports OPEN Functional Isolation of Tumor- Initiating Cells using Microfuidic- Based Migration Identifes Received: 17 July 2017 Accepted: 20 November 2017 Phosphatidylserine Decarboxylase Published: xx xx xxxx as a Key Regulator Yu-Chih Chen1,2,3, Brock Humphries4, Riley Brien1, Anne E. Gibbons4, Yu-Ting Chen5, Tonela Qyli4, Henry R. Haley4, Matthew E. Pirone4, Benjamin Chiang4, Annie Xiao4, Yu-Heng Cheng1, Yi Luan1, Zhixiong Zhang1, Jason Cong5, Kathryn E. Luker4, Gary D. Luker4,6,7 & Euisik Yoon1,7 Isolation of tumor-initiating cells currently relies on markers that do not refect essential biologic functions of these cells. We proposed to overcome this limitation by isolating tumor-initiating cells based on enhanced migration, a function tightly linked to tumor-initiating potential through epithelial-to-mesenchymal transition (EMT). We developed a high-throughput microfuidic migration platform with automated cell tracking software and facile recovery of cells for downstream functional and genetic analyses. Using this device, we isolated a small subpopulation of migratory cells with signifcantly greater tumor formation and metastasis in mouse models. Whole transcriptome sequencing of migratory versus non-migratory cells from two metastatic breast cancer cell lines revealed a unique set of genes as key regulators of tumor-initiating cells. We focused on phosphatidylserine decarboxylase (PISD), a gene downregulated by 8-fold in migratory cells. Breast cancer cells overexpressing PISD exhibited reduced tumor-initiating potential in a high-throughput microfuidic mammosphere device and mouse xenograft model. PISD regulated multiple aspects of mitochondria, highlighting mitochondrial functions as therapeutic targets against cancer stem cells. This research establishes not only a novel microfuidic technology for functional isolation of tumor- initiating cells regardless of cancer type, but also a new approach to identify essential regulators of these cells as targets for drug development.
    [Show full text]
  • Induction of CEMIP in Chondrocytes by Inflammatory Cytokines: Underlying Mechanisms and Potential Involvement in Osteoarthritis
    International Journal of Molecular Sciences Article Induction of CEMIP in Chondrocytes by Inflammatory Cytokines: Underlying Mechanisms and Potential Involvement in Osteoarthritis Takashi Ohtsuki 1 , Omer F. Hatipoglu 1, Keiichi Asano 2, Junko Inagaki 3, Keiichiro Nishida 4 and Satoshi Hirohata 1,* 1 Department of Medical Technology, Graduate School of Health Sciences, Okayama University, Okayama 700-8558, Japan; [email protected] (T.O.); [email protected] (O.F.H.) 2 Department of Molecular Biology and Biochemistry, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan; [email protected] 3 Department of Cell Chemistry, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan; [email protected] 4 Department of Orthopaediac Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1,Shikata-cho, Kita-ku, Okayama 700-8558, Japan; [email protected] * Correspondence: [email protected]; Tel.: +81-86-235-6897 Received: 30 March 2020; Accepted: 27 April 2020; Published: 29 April 2020 Abstract: In patients with osteoarthritis (OA), there is a decrease in both the concentration and molecular size of hyaluronan (HA) in the synovial fluid and cartilage. Cell migration-inducing hyaluronidase 1 (CEMIP), also known as hyaluronan (HA)-binding protein involved in HA depolymerization (HYBID), was recently reported as an HA depolymerization-related molecule expressed in the cartilage of patients with OA. However, the underlying mechanism of CEMIP regulation is not well understood. We found that CEMIP expression was transiently increased by interleukine-1β (IL-1β) stimulation in chondrocytic cells.
    [Show full text]